These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38127182)

  • 21. Crystallization and preliminary X-ray crystallographic studies of enoyl-acyl carrier protein reductase (FabI) from Psuedomonas aeruginosa.
    Lee JH; Park AK; Chi YM; Moon JH; Lee KS
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Feb; 67(Pt 2):214-6. PubMed ID: 21301088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural and enzymatic analyses reveal the binding mode of a novel series of Francisella tularensis enoyl reductase (FabI) inhibitors.
    Mehboob S; Hevener KE; Truong K; Boci T; Santarsiero BD; Johnson ME
    J Med Chem; 2012 Jun; 55(12):5933-41. PubMed ID: 22642319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance to AFN-1252 arises from missense mutations in Staphylococcus aureus enoyl-acyl carrier protein reductase (FabI).
    Yao J; Maxwell JB; Rock CO
    J Biol Chem; 2013 Dec; 288(51):36261-71. PubMed ID: 24189061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selectivity of Pyridone- and Diphenyl Ether-Based Inhibitors for the Yersinia pestis FabV Enoyl-ACP Reductase.
    Neckles C; Pschibul A; Lai CT; Hirschbeck M; Kuper J; Davoodi S; Zou J; Liu N; Pan P; Shah S; Daryaee F; Bommineni GR; Lai C; Simmerling C; Kisker C; Tonge PJ
    Biochemistry; 2016 May; 55(21):2992-3006. PubMed ID: 27136302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sunflower (Helianthus annuus) fatty acid synthase complex: enoyl-[acyl carrier protein]-reductase genes.
    González-Thuillier I; Venegas-Calerón M; Garcés R; von Wettstein-Knowles P; Martínez-Force E
    Planta; 2015 Jan; 241(1):43-56. PubMed ID: 25204631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do Go Chasing Waterfalls: Enoyl Reductase (FabI) in Complex with Inhibitors Stabilizes the Tetrameric Structure and Opens Water Channels.
    Maltarollo VG; Shevchenko E; Lima IDM; Cino EA; Ferreira GM; Poso A; Kronenberger T
    J Chem Inf Model; 2022 Nov; 62(22):5746-5761. PubMed ID: 36343333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a novel enoyl-acyl carrier protein reductase of diazaborine-resistant Rhodobacter sphaeroides mutant.
    Lee IH; Kim EJ; Cho YH; Lee JK
    Biochem Biophys Res Commun; 2002 Dec; 299(4):621-7. PubMed ID: 12459184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure of the Yersinia pestis FabV enoyl-ACP reductase and its interaction with two 2-pyridone inhibitors.
    Hirschbeck MW; Kuper J; Lu H; Liu N; Neckles C; Shah S; Wagner S; Sotriffer CA; Tonge PJ; Kisker C
    Structure; 2012 Jan; 20(1):89-100. PubMed ID: 22244758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The X-ray structure of Escherichia coli enoyl reductase with bound NAD+ at 2.1 A resolution.
    Baldock C; Rafferty JB; Stuitje AR; Slabas AR; Rice DW
    J Mol Biol; 1998 Dec; 284(5):1529-46. PubMed ID: 9878369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein EnvM is the NADH-dependent enoyl-ACP reductase (FabI) of Escherichia coli.
    Bergler H; Wallner P; Ebeling A; Leitinger B; Fuchsbichler S; Aschauer H; Kollenz G; Högenauer G; Turnowsky F
    J Biol Chem; 1994 Feb; 269(8):5493-6. PubMed ID: 8119879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crystal structure of enoyl-acyl carrier protein reductase (FabK) from Streptococcus pneumoniae reveals the binding mode of an inhibitor.
    Saito J; Yamada M; Watanabe T; Iida M; Kitagawa H; Takahata S; Ozawa T; Takeuchi Y; Ohsawa F
    Protein Sci; 2008 Apr; 17(4):691-9. PubMed ID: 18305197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of triclosan inhibition of bacterial fatty acid synthesis.
    Heath RJ; Rubin JR; Holland DR; Zhang E; Snow ME; Rock CO
    J Biol Chem; 1999 Apr; 274(16):11110-4. PubMed ID: 10196195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of the bacterial enoyl reductase FabI by triclosan: a structure-reactivity analysis of FabI inhibition by triclosan analogues.
    Sivaraman S; Sullivan TJ; Johnson F; Novichenok P; Cui G; Simmerling C; Tonge PJ
    J Med Chem; 2004 Jan; 47(3):509-18. PubMed ID: 14736233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural characterization of Porphyromonas gingivalis enoyl-ACP reductase II (FabK).
    Hevener KE; Santarsiero BD; Lee H; Jones JA; Boci T; Johnson ME; Mehboob S
    Acta Crystallogr F Struct Biol Commun; 2018 Feb; 74(Pt 2):105-112. PubMed ID: 29400320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Efficient and Economical Assay to Screen for Triclosan Binding to FabI.
    Demissie RD; Kabre P; Tuntland ML; Fung LW
    J Biomol Screen; 2016 Apr; 21(4):391-8. PubMed ID: 26538431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical and structural basis for Moraxella catarrhalis enoyl-acyl carrier protein reductase (FabI) inhibition by triclosan and estradiol.
    Katiki M; Neetu N; Pratap S; Kumar P
    Biochimie; 2022 Jul; 198():8-22. PubMed ID: 35276316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacophore and molecular docking guided 3D-QSAR study of bacterial enoyl-ACP reductase (FabI) Inhibitors.
    Lu X; Lv M; Huang K; Ding K; You Q
    Int J Mol Sci; 2012; 13(6):6620-6638. PubMed ID: 22837653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenylimidazole derivatives of 4-pyridone as dual inhibitors of bacterial enoyl-acyl carrier protein reductases FabI and FabK.
    Kitagawa H; Ozawa T; Takahata S; Iida M; Saito J; Yamada M
    J Med Chem; 2007 Sep; 50(19):4710-20. PubMed ID: 17713898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamics of Plasmodium falciparum enoyl-ACP reductase and implications on drug discovery.
    Lindert S; McCammon JA
    Protein Sci; 2012 Nov; 21(11):1734-45. PubMed ID: 22969045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.